Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study.

Authors:
Peng ZY; Yang CT; Lin WH; Yao WY; Ou HT and 1 more

Journal:
Cardiovasc Diabetol

Publication Year: 2023

DOI:
10.1186/s12933-023-01991-5

PMCID:
PMC10552437

PMID:
37794465

Journal Information

Full Title: Cardiovasc Diabetol

Abbreviation: Cardiovasc Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the Institutional Review Board of National Cheng Kung University Hospital (B-ER-108-474). Consent for publicationNot applicable. Competing interestsAuthors have nothings to be disclosed. Competing interests Authors have nothings to be disclosed."

Evidence found in paper:

"Funding This study was supported by grants from the Ministry of Science and Technology in Taiwan (grant MOST 109-2320-B-006-047-MY3) (recipient: Huang-Tz Ou). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025